Follow-up: Does it work? Can we afford it?

Surgical Oncology Clinics of North America

Volumn 9, Issue 4, 2000, Pages 827-834

  Beart R W , Jr ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; POLICY; REVIEW;

EID: 0033819049     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30122-4     Document Type: Review

References (65)

1. Use of preoperative ultrasound staging for treatment of rectal cancer
2. Postoperative follow-up for colorectal cancer: Who are we kidding?
3. Surveillance of colorectal cancer. Effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure
4. Guidelines for the use of carcinoembryonic antigen in colorectal cancer
5. Prevention and management of recurrent rectal cancer
6. Postoperative screening of patients with carcinoma of the colon
7. Management and survival of patients with adenocarcinoma of the colon and rectum. A national survey of the commission on cancer
8. Wound and port site recurrence
9. Management of recurrent rectal cancer
10. Postoperative follow-up of patients with carcinoma of the colon
11. Survival after repeat hepatic resection for recurrent colorectal hepatic metastases
12. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma
13. Follow-up after colorectal cancer: Current practice in the Netherlands
14. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
15. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer
16. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?
17. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation
18. CEA for monitoring colon cancer
19. CEA for monitoring colon cancer
20. The significance of allelic deletions and aneuploidy in colorectal carcinoma: Results of a 5-year follow-up study
21. CEA for monitoring colon cancer
22. Follow-up of patients with colorectal cancer
23. Colorectal cancer: The bases for a comprehensive follow-up
24. Brain metastases from colorectal carcinoma: The long term survivors
25. How tumor markers are used in the routine follow-up of breast and colorectal cancer: A survey of 29 Italian hospitals
26. Predictors of survival after curative resection of carcinoma of the colon and rectum
27. Case-based prediction of survival in colorectal cancer patients
28. Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques
29. Postoperative follow-up studies on cancer of the colon and rectum
30. Colon surveillance after colorectal cancer surgery
31. A prospective randomized study of follow-up after radical surgery for colorectal cancer
32. The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests
33. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer
34. Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer
35. Ultrasound, CT and colonoscopy of colonic cancer
36. Treatment of recurrent colorectal cancer
37. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon Cancer
38. Palliation for rectal cancer
39. CA 19-9 as a predictor of recurrence in patients with colorectal cancer
40. Laparoscopy and colon cancer: Is the port site at risk? A preliminary report. Invited commentary
41. Postoperative evaluation of patients with colorectal cancer
42. Follow-up after curative surgery for colorectal carcinoma: Randomized comparison with no follow-up
43. Follow-up of patients operated on for colorectal carcinoma
44. Results of salvage abdominoperineal resection for anal cancer after radiotherapy
45. Recurrent cancer of the colon
46. Colon surveillance after colorectal cancer surgery: Invited editorial
47. Follow-up of colorectal cancer: A meta-analysis
48. Recurrence and survival after surgical management of rectal cancer
49. Rectal cancer: Adequacy of surgical management
50. Diagnosis, therapy, and prognosis of recurrent colonic carcinoma
51. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients
52. Prognostic value of the Jass histopathologic classification in left colon and rectal cancer: A multivariate analysis
53. Transrectal ultrasound of rectal tumors
54. Standard follow-up of colorectal cancer patients: Finally, we can make practice guidelines based on evidence
55. Detection of pelvic recurrence of colorectal carcinoma: Prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT
56. Resection of colorectal liver metastases
57. The value of intensive follow-up after curative resection for colorectal carcinoma
58. Management of Recurrent Colorectal Cancer: Another Look at Carcinoembryonic Antigen-Detected Recurrence
59. Current follow-up strategies after resection of colon cancer: Results of a survey of members of the American Society of Colon and Rectal Surgeons
60. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
61. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA, and CEA in carcinomas of the colon
62. Outcomes after detection of metastatic carcinoma of the colon and rectum in a national hospital system
63. Resection of liver metastases from colorectal cancer: Are there any truly significant clinical prognosticators?
64. Anal complications in Crohn's disease
65. Gender related survival in colorectal cancer